Akanda (AKAN) Invested Capital (2020 - 2025)
Akanda's (AKAN) quarterly Invested Capital came in at $1.0 million in Q4 2025, up 185.4% year-on-year from $352814.0 in Q4 2024, and up 446.39% quarter-over-quarter from $184285.0 in Q2 2025.
Akanda (AKAN) Invested Capital (2020 - 2025) Analysis & Trends
Akanda's Invested Capital history runs 6 years deep, the most recent figure standing at $1.0 million for Q4 2025.
- On a quarterly basis, Invested Capital rose 185.4% year-over-year to $1.0 million in Q4 2025; TTM through Dec 2025 was $1.9 million, a 65.11% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 185.4% from the prior year.
- Invested Capital climbed to $1.0 million in Q4 2025 per AKAN's latest filing, from $184285.0 in the prior quarter.
- Across five years, Invested Capital topped out at $2.6 million in Q2 2022 and bottomed at $184285.0 in Q2 2025.
- The 5-year median for Invested Capital is $679617.0 (2022), against an average of $1.1 million.
- Across the five-year window, Invested Capital jumped 231.88% in 2023 and slumped 85.69% in 2024, its largest moves.
- Year by year, Invested Capital stood at $258900.0 in 2021, then jumped by 162.5% to $679617.0 in 2022, then soared by 231.88% to $2.3 million in 2023, then tumbled by 84.36% to $352814.0 in 2024, then surged by 185.4% to $1.0 million in 2025.
- Per Business Quant, the three latest AKAN Invested Capital figures stand at $1.0 million (Q4 2025), $184285.0 (Q2 2025), and $352814.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Akanda | 556,353.85 | 556,353.85 | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.01 Mn |
| Jun 30, 2025 | 184,285.00 |
| Dec 31, 2024 | 352,814.00 |
| Jun 30, 2024 | 354,586.00 |
| Dec 31, 2023 | 2.26 Mn |
| Jun 30, 2023 | 2.48 Mn |
| Dec 31, 2022 | 679,617.00 |
| Jun 30, 2022 | 2.57 Mn |
| Dec 31, 2021 | 258,900.00 |
| Dec 31, 2020 | 183,895.00 |